Clarion Co

Ntt Docomo, Inc.

Well Stone Co.

Nec Corporation

Satake Corporation

Mitsubishi Denki Kabushiki Kaisha

Panasonic Corporation

Takeshi Okamoto

Shoichi Minagawa

Yoichi Ishii

Hiroyuki Hosono

Teruo Niitsuma

Sayaka Makino

Wuri Andarmawanti Hapsari

Ryuichi Asai

Takeshi Terayama

Minami Ishii

Hideaki Takahashi

Takamasa Sakai

Takayuki Nemoto

Mikio Iwamura

Kenichiro Aoyagi

Kenji Sato

Syuichi Mitsutsuka

Shigeki Uebayashi

Anil Umesh

Takaaki Sato

Hiroyuki Kawano

Masafumi Masuda

Nobuo Mikoshiba

Tomoaki Kato

Kenji Mizutani

Hisaaki Yamakage

Tetsurou Ogushi

Rie Nagato

Akira Yao

Masaaki Murakami

Sayaka Ishii

Makoto Miyaji

Morihiro Niimi

Masaaki Kasada

Atsushi Fukui

Koji Kawakami

Hiromitsu Masumoto

Seiji Anzai

Provided are: a method of producing a therapeutic agent for skin lesions suitable for treatment or prevention of a skin lesion such as a bedsore; and a therapeutic agent for skin lesions produced by the production method. The method of producing a therapeutic agent for skin lesions characterized by including a mixing step of mixing earthworm castings with water and a collecting step of collecting vaporized water generated from a mixture obtained in the mixing step to obtain a liquid; and the therapeutic agent for skin lesions produced by the production method. It is preferred to further mix an organic substance together with the earthworm castings and the water in the mixing step.

Method for producing therapeutic agent for skin lesions, and therapeutic agent for skin lesions

Provided are: a method for producing a nasal drop composition suitable for treatment or prevention of a disease or symptom in the nasal cavities; and a nasal drop composition produced by the production method. The nasal drop composition production method characterized by including a mixing step of mixing earthworm castings with water and a collecting step of collecting vaporized water generated from a mixture obtained in the mixing step to obtain a liquid; and the nasal drop composition produced by the production method. It is preferred to further mix an organic substance together with the earthworm castings and the water in the mixing step.

Production method of nasal drop composition, and nasal drop composition

A flow rate measurement device improves the flow rate measurement accuracy without increasing the size of the metering tank. The flow rate measurement device includes a metering tank having a supply port at its upper portion and a discharge port at its lower portion, an on-off valve that opens and closes a flow channel inside the metering tank, a weight measurement unit that measures a weight of the metering tank, and flow rate computing unit that supplies powders and/or grains continuously from the supply port to the metering tank, computes a flow rate of the powders and/or grains multiple times in a temporally-overlapped state on the basis of the weight of the metering tank measured by the weight measurement unit in a state where the on-off valve is closed, and computes an average flow rate of the powders and/or grains on the basis of the flow rate computed multiple times.

Weight and flow rate measurement device and weight and flow rate measurement method

Provided are: a method for producing a deodorant which is derived from earthworm castings and can be used in a liquid form; and a deodorant. The deodorant production method characterized by including a mixing step of mixing earthworm castings with water and a collecting step of collecting vaporized water generated from a mixture obtained in the mixing step to obtain a liquid; and the deodorant produced by the production method. It is preferred to further mix an organic substance together with the earthworm castings and the water in the mixing step.

Deodorant production method and deodorant

Provided are: a method for producing an oral composition suitable for treatment or prevention of a disease or symptom in the oral cavity; and an oral composition produced by the production method. The oral composition production method characterized by including a mixing step of mixing earthworm castings with water and a collecting step of collecting vaporized water generated from a mixture obtained in the mixing step to obtain a liquid; and the oral composition produced by the production method. It is preferred to further mix an organic substance together with the earthworm castings and the water in the mixing step.

Method for producing oral composition, and oral composition

Method of producing nasal drop composition by mixing earthworm castings with water

A roll machine for milling includes a tube type supplying unit, feed rolls, a feeder gate plate, and main rolls. A load detectorfor detecting stock level is provided on inlet partof the tube type supplying unit, a detection rodfor detecting the level is suspended in the tube type supplying unit, and one end of the detection rodis connected to the load detector

Stock level detector for roll machine for milling

An object of the present invention is to provide: a Tau protein production accelerator containing a natural product as an active ingredient; a therapeutic or preventive agent for a disease caused by Tau protein deficiency; and a therapeutic or preventive food composition for a disease caused by Tau protein deficiency. Provided are: a Tau protein production accelerator containing a dry powder ground product and/or extract of an earthworm as an active ingredient; a therapeutic or preventive agent for a disease caused by Tau protein deficiency; and a therapeutic or preventive food composition for a disease caused by Tau protein deficiency. The disease caused by Tau protein deficiency is preferably Alzheimer's disease.

Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency

An object of the present invention is to provide: a Tau protein production accelerator containing a natural product as an active ingredient; a therapeutic or preventive agent for a disease caused by Tau protein deficiency; and a therapeutic or preventive food composition for a disease caused by Tau protein deficiency. Provided are: a Tau protein production accelerator containing a dry powder, ground product and/or extract of an earthworm as an active ingredient; a therapeutic or preventive agent for a disease caused by Tau protein deficiency; and a therapeutic or preventive food composition for a disease caused by Tau protein deficiency. The disease caused by Tau protein deficiency is preferably Alzheimer's disease.

An object of the present invention is to provide: a catecholamine production accelerator comprising a natural product as an active ingredient; a therapeutic agent and preventive agent for diseases caused by catecholamine deficiency; and food compositions for the treatment or prevention of diseases caused by catecholamine deficiency. Provided are: a catecholamine production accelerator comprising a dry powder, ground product and/or extract of an earthworm as an active ingredient; a therapeutic agent and preventive agent for a disease caused by catecholamine deficiency; and loud compositions for the treatment or prevention of a disease caused by catecholamine deficiency. It is preferred that the disease caused by catecholamine deficiency be selected from the group consisting of Alzheimer's disease and Parkinson's disease.

Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency

A radio access device includes a controller signal processing unit (RNSAP unit) that processes a signal exchanged with a radio network controller (RNC); and a switching center signal processing unit (RANAP unit) that processes a signal exchanged with a switching center. The RNSAP unit requests to establish a communication path between the radio access device and the RNC and a communication path between the RNC and a BTS by transmitting a request signal to the RNC. Subsequent to receiving an acknowledgement signal corresponding to the request signal from the RNC, the RANAP unit requests to establish a communication path between the switching center and the RNC. Subsequent to receiving, by the RANAP unit, an acknowledgement signal corresponding to the request signal from the switching center, a communication path between the radio access device and the UE is released.

Radio access device and handover method

A mobile communication method according to the present invention includes: a step of a mobile switching center MME managing access information that defines accessible CSG-ID of a mobile station UE; a step of the mobile switching center MME accommodating a combination of eNB-IDs and CSG-IDs of a radio base station HeNBfrom a gateway device HeNB-GW; and a step of the mobile switching center MME determining whether the mobile station UE is accessible to the radio base station HeNBbased on identification information of the mobile station UE and eNB-ID of the radio base station HeNBincluded in 'HO Required' received from the radio base station eNB, which are included in the handover request signal, with reference to the access information and the combination.

Mobile communication method

A laser light source includes an optical resonator and a first optical filter. The first optical filter is provided outside the optical resonator, and does not constitute an optical resonator structure. For example, antireflection coating is performed on the optical resonator side of the first optical filter and on a surface on the opposite side thereto, and a reflection structure in which light after passing through the first optical filter is reflected in the direction to the optical resonator is not present on an optical path of the light.

Laser light source

Growing community of inventors

Tokyo, Japan

Takeshi Okamoto